Log in
Enquire now
Locus Biosciences

Locus Biosciences

Locus Biosciences is a biotechnology company developing CRISPR-Cas3-engineered precision antibacterial products.

OverviewStructured DataIssuesContributors

Contents

locuspharma.com
locus-bio.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Cell therapy
Cell therapy
Healthcare
Healthcare
Therapeutics
Therapeutics
CRISPR
CRISPR
Phage therapy
Phage therapy
Consumer biotechnology
Consumer biotechnology
Engineering
Engineering
Biomedical engineering
Biomedical engineering
...
Location
Blue Bell, Pennsylvania
Blue Bell, Pennsylvania
Morrisville, North Carolina
Morrisville, North Carolina
0
North Carolina
North Carolina
United States
United States
Raleigh, North Carolina
Raleigh, North Carolina
B2X
B2B
B2B
CEO
‌
Paul Garofolo
0
Founder
‌
Nick Taylor
0
‌
Paul Garofolo
0
‌
Chase Beisel
Rodolphe Barrangou
Rodolphe Barrangou
Charles Gersbach
Charles Gersbach
‌
Dave Ousterout
0
AngelList URL
angel.co/company/lo...biosciences
Legal Name
Locus Biosciences, Inc.
Legal classification
Corporation
Corporation
Date Incorporated
2015
Number of Employees (Ranges)
51 – 200
Email Address
info@locus-bio.com0
Phone Number
+19194954510
Full Address
523 Davis Dr Ste 350 Morrisville, NC, 27560-7166 United States0
CIK Number
1,664,639
Investors
Abstract Ventures
Abstract Ventures
Duke University
Duke University
0
ARTIS Ventures
ARTIS Ventures
0
Starlight Ventures
Starlight Ventures
North Carolina State University
North Carolina State University
0
Viking Global Investors
Viking Global Investors
Tencent
Tencent
0
Scott Hataway
Scott Hataway
0
...
Founded Date
2015
Total Funding Amount (USD)
117,503,000
Latest Funding Round Date
May 18, 2022
Board of Directors
Stuart Peterson
Stuart Peterson
0
‌
Austin Walne
0
‌
Bary Bailey
0
Claire Leurent
Claire Leurent
0
Kyle Kurpinski
Kyle Kurpinski
0
‌
Paul Garofolo
0
CFO
‌
Joseph Nixon
0
Latest Funding Type
Series B
Series B
Patents Assigned (Count)
1
Wellfound ID
locus-biosciences
Technologies Used
CRISPR
CRISPR
Country
United States
United States
0

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
35,000,000
Wikidata ID
Q65081117

Locus Biosciences is a biotechnology company headquartered in Raleigh, North Carolina and was founded in 2015 by Charles Gersbach, Chase Beisel, Dave Ousterout, Nick Taylor, Paul Garofolo, and Rodolphe Barrangou.

Locus Biosciences develops CRISPR-engineered phage therapeutics, and uses Type I CRISPR-Cas3 system to destroy the DNA of target bacteria cells. Locus is the exclusive global licensee of the foundational CRISPR-Cas3 patent estate from North Carolina State University and Duke University. Although CRISPR-Cas9 is being used by a variety of companies to treat human diseases, Locus is the only company using CRISPR-Cas3 to tackle the problem of multidrug-resistant bacteria.

Locus's CRISPR-Cas3-engineered phage ("crPhage") platform is notable because it combines the safety profile of phages with the efficacy advantage of CRISPR. crPhage products kill target bacteria, including antibiotic-resistant superbugs, while leaving the many species of good bacteria in the body unharmed. The acquisition of EpiBiome's automation platform helps Locus develop these crPhage products to treat antibiotic-resistant bacterial infections and precisely edit the microbiome more rapidly.

Funding
Series A

On November 14, 2017 Locus Biosciences completed their series A funding round with $19 million in funding from Artis Ventures (lead investor), Starlight Ventures, North Carolina Biotechnology Center, and Abstract Ventures.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Locus Biosciences

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.